SCHEMBL7791014

SCHEMBL7791014

COc1cc2cnc(Nc3ccccc3I)nc2cc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C1R P00736 2/20 0.51
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
KDM4E B2RXH2 2/20 0.46
LRRK2 Q5S007 1/20 0.44
EGFR P00533 2/20 0.43
INSR P06213 1/20 0.43
IGF1R P08069 1/20 0.43
ALK Q9UM73 1/20 0.43
RAB9A P51151 1/20 0.43
FGFR1 P11362 2/20 0.42
FGFR2 P21802 1/20 0.42
FGFR4 P22455 1/20 0.42
FGFR3 P22607 1/20 0.42
PTK2 Q05397 1/20 0.42
PDGFRB P09619 4/20 0.42
PDGFRA P16234 4/20 0.42
MAPT P10636 2/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7799232 0.85 CSF1R (0.49) ALDH1A1SMN1; SMN2KDM4ELRRK2EGFR
SCHEMBL7800417 0.84 LRRK2 (0.53) ALDH1A1SMN1; SMN2KDM4ELRRK2EGFR
SCHEMBL7791030 0.84 FLT1 (0.55) ALDH1A1SMN1; SMN2KDM4ELRRK2EGFR
SCHEMBL7790969 0.84 EGFR (0.55) ALDH1A1SMN1; SMN2KDM4ELRRK2EGFR
SCHEMBL1539121 0.84 RET (0.55) ALDH1A1SMN1; SMN2KDM4ELRRK2EGFR
SCHEMBL7799243 0.81 EGFR (0.58) SMN1; SMN2LRRK2EGFRPTK2KMT2A
SCHEMBL7757002 0.81 PDGFRB (0.59) ALDH1A1SMN1; SMN2KDM4EEGFRFGFR2
SCHEMBL7800595 0.80 LRRK2 (0.46) C1RALDH1A1SMN1; SMN2KDM4ELRRK2
SCHEMBL7800394 0.80 AURKA (0.53) KDM4EALKRAB9AFGFR1FGFR2
SCHEMBL7790973 0.80 RET (0.57) ALDH1A1SMN1; SMN2KDM4ELRRK2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1162974-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
EP-1163228-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
WO-2000056338-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed
WO-2000056720-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed